Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma - PubMed (original) (raw)

Comment

. 2002 Nov 21;347(21):1721-2; author reply 1721-2.

doi: 10.1056/NEJM200211213472119.

• PMID: 12444194
• DOI: 10.1056/NEJM200211213472119

Comment

Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma

Andreas Geier et al. N Engl J Med. 2002.

No abstract available

PubMed Disclaimer

Comment on

• Hepatitis B e antigen and the risk of hepatocellular carcinoma.
  Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ; Taiwan Community-Based Cancer Screening Project Group. Yang HI, et al. N Engl J Med. 2002 Jul 18;347(3):168-74. doi: 10.1056/NEJMoa013215. N Engl J Med. 2002. PMID: 12124405
• Hepatitis B e Antigen--the dangerous endgame of hepatitis B.
  Liang TJ, Ghany M. Liang TJ, et al. N Engl J Med. 2002 Jul 18;347(3):208-10. doi: 10.1056/NEJMe020060. N Engl J Med. 2002. PMID: 12124411 No abstract available.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information